1 |
Budkaew J, Chumworathayi B (2013). Knowledge and attitudes toward palliative terminal cancer care among Thai generalists. Asian Pac J Cancer Prev, 14, 6173-80.
과학기술학회마을
DOI
ScienceOn
|
2 |
Fredheim OM, Dale O, Kaasa S, et al (2010). Morphine or oxycodone tablets for pain? Tidsskr Nor Laegeforen, 130, 1479-81.
DOI
ScienceOn
|
3 |
Lee YJ, Hyun MK, Jung YJ, et al (2014). Effectiveness of education interventions for the management of cancer pain: a systematic review. Asian Pac J Cancer Prev, 15, 4787-93.
과학기술학회마을
DOI
ScienceOn
|
4 |
Gong XD, Wang JY, Liu F, et al (2013). Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain. Asian Pac J Cancer Prev, 14, 2937-43.
과학기술학회마을
DOI
ScienceOn
|
5 |
Ise Y, Wako T, Miura Y, et al (2009). Cost-effective analysis of rotation from sustained-release morphine tablet to transdermal fentanyl of matrix type or sustained-release oxycodone tablet. Gan To Kagaku Ryoho, 36, 2599-603.
|
6 |
King S J, Reid C, Forbes K, et al (2011). A systematic review of oxycodone in the management of cancer pain. Palliat Med, 25, 454-70.
DOI
ScienceOn
|
7 |
Liang SY, Chen KP, Tsay SL, et al (2013). Relationship between belief about analgesics, analgesic adherence and pain experience in Taiwanese cancer outpatients. Asian Pac J Cancer Prev, 14, 713-6.
과학기술학회마을
DOI
ScienceOn
|
8 |
Mahigir F, Khanehkeshi A, Karimi A (2013). Psychological treatment for pain among cancer patients by rational-emotive behavior therapy--efficacy in both India and Iran. Asian Pac J Cancer Prev, 13, 4561-5.
과학기술학회마을
DOI
ScienceOn
|
9 |
Meserve J R, Kaye A D, Prabhakar A, et al (2014). The role of analgesics in cancer propagation. Best Pract Res Clin Anaesthesiol, 28, 139-51.
DOI
ScienceOn
|
10 |
Mercadante S, Porzio G, Gebbia V (2014). New opioids. J Clin Oncol, 32, 1671-6.
DOI
ScienceOn
|
11 |
Mika J, Popiolek-Barczyk K, Rojewska E, et al (2014). Deltaopioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain. PLoS One, 9, e104420.
DOI
|
12 |
Riley J, Branford R, Droney J, et al (2014). Morphine or oxycodone for cancer-related pain? A randomized, openlabel, controlled trial. J Pain Symptom Manage, 26, [Epub ahead of print].
|
13 |
Shen H, Hu X, Szymusiak M, et al (2014). Orally administered nanocurcumin to attenuate morphine tolerance: comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles. Mol Pharm, 10, 4556-51.
|
14 |
Shinde S, Gordon P, Sharma P, et al (2014). Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements? Support Care Cancer, 29, [Epub ahead of print].
|
15 |
Simon S M, Schwartzberg L S (2014). A review of rapid-onset opioids for breakthrough pain in patients with cancer. J Opioid Manag, 10, 207-15.
DOI
|
16 |
Wiffen P J, Derry S, Moore R A, et al (2014). Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain. Cochrane Database Syst Rev, 5, CD011056.
|
17 |
Zhou B, Wang J, Yan Z, et al (2012). Liver cancer: effects, safety, and cost-effectiveness of controlled-release oxycodone for pain control after TACE. Radiology, 262, 1014-21.
DOI
|
18 |
Yang J, Yang H, Du X, et al (2014). Morphine and DAMGO produce an opposite effect on presynaptic glutamate release via different downstream pathways of opioid receptors in the basolateral amygdala. Neuropharmacology, 86C, 353-61.
|